Skip to content

Triamcinolone acetonide

Allernaze, Azmacort, Kenalog, Kenalog In Orabase, Nasacort, Nasacort 24 Hour, Nasacort Hfa, Triamcinolone Acetonide, Triesence, Trivaris, Zilretta (triamcinolone acetonide) is a small molecule pharmaceutical. Triamcinolone acetonide was first approved as Allernaze on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA. It is known to target glucocorticoid receptor and Ancestral Glucocorticoid Receptor2. Triderm's patents are valid until 2031-08-04 (FDA).
Trade Name Allernaze, Azmacort, Kenalog, Kenalog In Orabase, Nasacort, Nasacort 24 Hour, Nasacort Hfa, Triamcinolone Acetonide, Triesence, Trivaris, Zilretta
Common Name Triamcinolone acetonide
Indication adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, berylliosis, bronchial spasm, dermatitis herpetiformis, erythema multiforme, facial dermatoses, foot dermatoses, hand dermatoses, hemolytic anemia, hypercalcemia, inflammation, leg dermatoses, multiple sclerosis, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, scalp dermatoses, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
Drug Class Steroids (not prednisolone derivatives); topical steroids (acetal derivatives)
Triamcinolone acetonide
Get full access now